Abstract | BACKGROUND:
Acute renal failure from ischemia significantly contributes to morbidity and mortality in clinical settings, and strategies to improve renal resistance to ischemia are urgently needed. Here, we identified a novel pathway of renal protection from ischemia using ischemic preconditioning (IP). METHODS AND FINDINGS: For this purpose, we utilized a recently developed model of renal ischemia and IP via a hanging weight system that allows repeated and atraumatic occlusion of the renal artery in mice, followed by measurements of specific parameters or renal functions. Studies in gene-targeted mice for each individual adenosine receptor (AR) confirmed renal protection by IP in A1(-/-), A2A(-/-), or A3AR(-/-) mice. In contrast, protection from ischemia was abolished in A2BAR(-/-) mice. This protection was associated with corresponding changes in tissue inflammation and nitric oxide production. In accordance, the A2BAR-antagonist PSB1115 blocked renal protection by IP, while treatment with the selective A2BAR-agonist BAY 60-6583 dramatically improved renal function and histology following ischemia alone. Using an A2BAR-reporter model, we found exclusive expression of A2BARs within the reno-vasculature. Studies using A2BAR bone-marrow chimera conferred kidney protection selectively to renal A2BARs. CONCLUSIONS: These results identify the A2BAR as a novel therapeutic target for providing potent protection from renal ischemia.
|
Authors | Almut Grenz, Hartmut Osswald, Tobias Eckle, Dan Yang, Hua Zhang, Zung Vu Tran, Karin Klingel, Katya Ravid, Holger K Eltzschig |
Journal | PLoS medicine
(PLoS Med)
Vol. 5
Issue 6
Pg. e137
(Jun 24 2008)
ISSN: 1549-1676 [Electronic] United States |
PMID | 18578565
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 1-propyl-8-(4-sulfophenyl)xanthine
- Adenosine A2 Receptor Antagonists
- Aminopyridines
- BAY 60-6583
- Receptor, Adenosine A2B
- Xanthines
- Nitric Oxide
- Adenosine
|
Topics |
- Adenosine
(metabolism)
- Adenosine A2 Receptor Antagonists
- Aminopyridines
(pharmacology)
- Animals
- Blood Vessels
(metabolism)
- Cytoprotection
(drug effects, genetics)
- Extracellular Fluid
(metabolism)
- Female
- Inflammation
(genetics)
- Ischemia
(genetics)
- Kidney
(blood supply, drug effects, metabolism, pathology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Nitric Oxide
(metabolism)
- Receptor, Adenosine A2B
(genetics, metabolism, physiology)
- Signal Transduction
(genetics)
- Xanthines
(pharmacology)
|